NM_017739.4:c.386G>A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3_Moderate
The NM_017739.4(POMGNT1):c.386G>A(p.Arg129Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000806 in 1,613,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R129W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_017739.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251232Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135854
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461738Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727152
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152128Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74324
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2O Pathogenic:1
Delayed speech and language development; gait ataxia; global developmental delay; infantile onset; microcephaly; motor delay; neurodevelopmental delay; poor speech; postnatal microcephaly; strabismus. -
Muscular dystrophy-dystroglycanopathy Uncertain:1
The p.Arg129Gln variant in POMGNT1 has been reported in one individual, in the homozygous state, with POMGNT1-associated muscular dystrophy-dystroglycanopathy (PMID: 33175337), and has been identified in 0.01% (2/16230) of African/African American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs770188918). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID #471406) and has been interpreted pathogenic by Medical Genetics Laboratory (Tarbiat Modares University) and as a variant of uncertain significance by Natera, Inc., Invitae, and Eurofins NTD LLC (GA). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. One additional likely pathogenic variant, resulting in a different amino acid change at the same position, p.Arg129Trp, has been reported in association with disease in the literature/ClinVar, slightly supporting that a change at this position may not be tolerated (PMID: 28688748, 30961548, 34324503/Variation ID: 558512). In summary, the clinical significance of the p.Arg129Gln variant is uncertain. ACMG/AMP Criteria applied: PM3_Supporting, PM5_Supporting (Richards 2015). -
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3;C3150417:Autosomal recessive limb-girdle muscular dystrophy type 2O Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 129 of the POMGNT1 protein (p.Arg129Gln). This variant is present in population databases (rs770188918, gnomAD 0.01%). This missense change has been observed in individual(s) with muscular dystrophy‚Äëdystroglycanopathy (PMID: 33175337). ClinVar contains an entry for this variant (Variation ID: 471406). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on POMGNT1 protein function. This variant disrupts the p.Arg129 amino acid residue in POMGNT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28688748, 30961548, 34324503; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Muscle eye brain disease Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at